Belite Bio Inc ADR (BLTE) had the highest return between April 1, 2022 and September 30, 2022 by a mid-cap US stock, returning 168.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Belite Bio Inc ADR (BLTE) | 4/1/2022 - 9/30/2022 | 168.4% |
Akero Therapeutics (AKRO) | 4/1/2022 - 9/30/2022 | 137.45% |
Rhythm Pharmaceuticals (RYTM) | 4/1/2022 - 9/30/2022 | 113.23% |
Verona Pharma PLC ADR (VRNA) | 4/1/2022 - 9/30/2022 | 101.98% |
Scorpio Tankers (STNG) | 4/1/2022 - 9/30/2022 | 96.67% |
New Oriental Education & Technology (EDU) | 4/1/2022 - 9/30/2022 | 94.88% |
H&R Block (HRB) | 4/1/2022 - 9/30/2022 | 64.99% |
Celsius (CELH) | 4/1/2022 - 9/30/2022 | 64.01% |
Griffon (GFF) | 4/1/2022 - 9/30/2022 | 57.99% |
TAL Education (TAL) | 4/1/2022 - 9/30/2022 | 54.86% |
TransMedics (TMDX) | 4/1/2022 - 9/30/2022 | 54.02% |
Catalyst Pharmaceuticals (CPRX) | 4/1/2022 - 9/30/2022 | 53.84% |
Alliance Resource Partners (ARLP) | 4/1/2022 - 9/30/2022 | 52.67% |
PBF Energy (PBF) | 4/1/2022 - 9/30/2022 | 44.99% |
Huron Consulting (HURN) | 4/1/2022 - 9/30/2022 | 44.94% |
ELF Beauty (ELF) | 4/1/2022 - 9/30/2022 | 43.97% |
Calix (CALX) | 4/1/2022 - 9/30/2022 | 42.65% |
Lyell Immunopharma (LYEL) | 4/1/2022 - 9/30/2022 | 42.05% |
Modine Manufacturing (MOD) | 4/1/2022 - 9/30/2022 | 41.58% |
Sarepta Therapeutics (SRPT) | 4/1/2022 - 9/30/2022 | 40.96% |
Nuvalent (NUVL) | 4/1/2022 - 9/30/2022 | 40.16% |
Enphase Energy (ENPH) | 4/1/2022 - 9/30/2022 | 38.02% |
Agilysys (AGYS) | 4/1/2022 - 9/30/2022 | 37.44% |
HF Sinclair (DINO) | 4/1/2022 - 9/30/2022 | 37.02% |
Murphy USA (MUSA) | 4/1/2022 - 9/30/2022 | 36.76% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
